African Journal of Biomedical
Research, Vol. 5, No. 3, Sept, 2002, pp. 137-140
Views from the Humanities
INFORMATION SOURCES
AND UTILIZATION
PATTERNS OF PHARMACEUTICAL SCIENTISTS IN NIGERIA
OPEKE, ROSALINE; OSUNKUNLE,
SOLA AND OKWILAGWE,
O.A.
Department of Library,
Archival and Information Studies,
University of lbadan. Ibadan. Nigeria
Received: July 2001
Accepted in final form: April 2002
Code Number:
md02028
The study
investigated the adequacy of pharmaceutical scientists' information environment
in feeding their occupational activities. Data was collected through
observation and through questionnaire administration to all the twenty-seven
scientists
in two large pharmaceutical companies in Lagos, Nigeria. Findings
revealed that pharmaceutical scientists carried out their work activities
under less than optimal information
conditions and with out-dated information. Although scientists were found to
rely a lot on oral sources (colleagues and so on) for information, documented
sources were identified as being more reliable. A recommendation was made to
the pharmaceutical companies to improve the information resources available for
the use of their scientists through the provision of functional and effective
information centres and through the provision of basic skills in information
handling.
Key
Words. Information, Scientists, Pharmacists information; Information sources
and use
INTRODUCTION
There is no clearly
defined homogenous group of Pharmaceutical Scientists. The pharmaceutical
industry is concerned with the art and science of preparing from natural and
synthetic sources) suitable
and convenient materials for distribution and use in the treatment and prevention
of disease. It embraces knowledge of the identification, selection, pharmacological
action, preservation, combination, analysis and standardization of drugs and
medicines, (Deno, 1996). Pharmaceutical scientists are thus involved in the
research, development and manufacture of remedial preparations such as antibiotics,
vaccines and other types of drugs.
The sequence of events leading
towards the evolution of a new drug, from synthesis to approval (for marketing)
by the government is
a long one. Enroute, the following scientists will be found - Chemists, Biochemists,
a variety of Biologists, Pharmacists, and towards the end of the journey, Physicians.
The pharmaceutical industry provides an outstanding example of a diversity of
scientific skills united and directed towards the achievement of therapeutic
goals (Cooper 1970).
It has been suggested that
for scientists and
technologists, information needs arise at three levels. First, at the level
of research and development, second at the level of planning and third, at the
level of execution (Atinmo, 1998). Key areas of information need in the production
of drugs include chemical and physiochemical information, biological and biomedical
information as well as toxicology and drug metabolism
information (Pickering, 1990). The information needed by the science and technology
community has been categorized into formal and
informal sources (Singh, 1981). Formal sources refer to something that is written
down and informal sources as oral. While three types of formal sources are
recognized - primary, secondary and tertiary (Singh, 1981), it is agreed that
scientists and technologists would seek information through informal channels
first before checking on formal sources (Odeinde, 1975; Gorman, 1995; Gravois,
1995). This had earlier been noted by Hanson (1971), who observed the existence
of networks among scientists/technologists which are made up of colleagues, ex-colleagues,
fellow students from the past, acquaintances made at professional meetings, fellow
members of committees, and confirmed by Ehikhamenor (1990) who observed that
among information channels rated highly by scientists were conferences and seminars,
as well as correspondence and exchange of off prints or reprints. The most important
source of informal information defined by Graiewska-Vickery (1976) was personal
communication which is an oral or written social interaction between people. Scientists
use information not only to solve problems, but to clear uncertainties (Losee,
1994). It is important for anyone providing this service to ensure its appropriateness
to users' needs and to be ready to adapt promptly as those needs change (Webb
1995).
In this study, we investigated
information requirements and utilization patterns of pharmaceutical scientists
in two large
pharmaceutical companies based in Lagos Nigeria. Its purpose was to find out
the
adequacy of scientsts' information environment - for their occupational
activities.
METHODOLOGY
The two multinational companies
investigated were
SmithKline-Beecham and Vitabiotics. SmithKline-Beecham was incorporated in Nigeria
in 1971, and produced Over The Counter (OTC) medicines such as pain killers,
Andrews
Liversalts,
anti-malarias, and diuretics. Vitabiotics Ltd was established in Nigeria in
1975 as an affiliate of Meyer
Pharmaceuticals, India. Twenty-two different pharmaceutical products (including
antimalarias, analgesics, Multivitamins anti-asthmatics, sedatives) were manufactured
by Vitabiotics while there was also an ongoing research on the production of
ointments. Between them both companies had a total of twenty seven scientists;
eleven in SmithKline Beecham
and sixteen in Vitabiotics
Twenty seven pharmaceutical
scientists in the two companies mentioned were included in this study while
the instrument of data gathering was the questionnaire. The questionnaire consisted
of twenty five
questions. The first section of the questionnaire sought answers to respondents'
background, their qualification, age, gender, position in the company, area of
specialization and years of experience. The second section concentrated on respondents'
work, activities and the information needs arising from them. The use of library
and information centre services constituted the third section with explorations
of degree of importance in which certain formal and informal information sources
were held. The fourth section explored the participation of the respondents
in professional meetings and the fifth section looked at their information utilization
patterns, while the last section addressed problems faced by respondents in sourcing
for information
Statistical analysis: Univariate
and bi-variate analytical
methods were used to present and interpret the data collected.
RESULTS AND DISCUSSION
The subjects comprised of 13 pharmacists,
7 chemists, 2
microbiologists, 2 biochemists and I food technologist. Surprisingly, only 6
had higher degrees. A third of the total population were women. Pharmacists'
key areas of work were research and the development of new drugs. The chemists
were involved in research, in the development of new drugs and in upgrading existing
drugs, while the two microbiologists and the only food technologist were responsible
for product quality control. Also involved in quality control were two of the
pharmacists.
For these work activities,
respondents consulted mainly primary (journals, tables/figures) and secondary
sources (books, abstracts. Nevertheless, they noted that their first port of
call for
information were colleagues. Unfortunately, this source was often unsatisfactory,
although respondents said that this would not stop them from still consulting
their colleagues first on most issues. Meetings, symposia and conferences also
constituted important sources of information for pharmaceutical scientists. Over
90% of scientists took part in meetings/symposia regularly and they saw these
sources as providing opportunity
for interaction with professional colleagues:
Table 1: Value placed on Information Sources
by respondents a
Information sources
|
Very Essential
|
Essential
|
Not Essential
|
Colleagues
|
5 (20.8)
|
17 (70.8)
|
2 (8.3)
|
Books
|
22 (88.0)
|
3 (12.0)
|
0
|
Journals
|
18 (72.0))
|
7 (28.0)
|
0
|
Abstracts
|
13 (59.1)
|
8 (36.4)
|
1 (45.0))
|
Indexes
|
8 (40.0))
|
9 (45.0)
|
3 (15.0)
|
Electronic databases
|
12 (60.0))
|
7 (35.0)
|
3 (15.0)
|
Reports
|
13 (56.5)
|
8 (34.8)
|
2 (8.7)
|
Conference proceedings
|
13 (68.4)
|
2 (10.5)
|
4 (21.1)
|
Standards
|
22 (95.7)
|
1 (43.0)
|
0
|
Theses
|
8 (40.0))
|
9 (45.0)
|
3 (15.0)
|
Patents
|
7 (36.8)
|
9 (47.4)
|
3 (15.8)
|
Trade literature
|
10 (45.5)
|
10 (45.5)
|
2 (9.0)
|
aPercentages
of values are presented in parenthesis
In spite of scientists' apparent
remarkable reliance on oral sources of information such as communication with
colleagues, documented sources still appeared to be the most desirable. In
other words, these scientists placed more value on information coming from
documented
sources, be they primary or secondary than on oral sources. As Table 1 shows,
while 95.7% and 88% of respondents described Standards and Books as "very
essential" sources of information for them, only 20.8% refered to oral sources/colleagues
as "very essential", while, 70.8% of respondents saw these sources
as merely essential.
Overall information was used
to improve product
quality. This was the assertion of 60% of respondents, followed by 48% of the
respondents who said that they used information to update professional and scientific
knowledge (Table 2). A mere 16% indicated that they required information for
the development of new drugs even though respondents had earlier ticked this
work activity as a key aspect of their work.
A reason for this discrepancy
could be that although the development of new drugs' was one of the job descriptions
of the
respondents, they seldom performed this activity.
Rather, they concentrate their
research activities more on improving the quality of existing drugs leaving
(perhaps) the development of new drugs to their parent bodies (outside the
country).
Information centres were
poorly developed in both companies. Preliminary investigations revealed that
the companies had very small informal collections of information resources
such as books, journals and
other primary information resources. Trained staff such as a librarian manages
none of the information centres.
Table 2: Patterns of Information
Use by respondents
The respondents indicated
a high level of dissatisfaction with information resources available in company
collections. Most of them did not participate actively in the selection of
information resources for their company while current awareness services and
Selective
Dissemination of Information (SDI) policies were not well established. Scientists
apparently had to rely on their private collections and those of other colleagues
within and outside the company.